🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — August 21, 2026

The six filings for the S&P 500 Consumer Staples stream reveal a clear divergence in insider behavior: top executives at Walmart and Coca-Cola are executing significant, pre-planned stock sales, signaling potential near-term caution or portfolio diversification, while Procter & Gamble is issuing large equity awards to its leadership team, indicating a focus on long-term retention and alignment. The period-over-period data from the enriched filings shows no direct revenue or margin trends, but the insider activity pattern is notable—two major consumer staples companies saw insider sales totaling over $4.8 million, which could be a sector-level signal of perceived overvaluation or a need for liquidity. In contrast, P&G's awards to four top executives, including the CFO and business unit CEOs, suggest confidence in future performance and a desire to lock in key talent. The lack of forward-looking guidance or capital allocation changes in these filings limits the catalyst calendar, but the insider trading data provides actionable intelligence for investors to monitor. Overall, the sector appears stable but with pockets of insider caution that warrant attention, especially given the high materiality of the Coca-Cola sale.

6 high priority 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 21, 2026

The 19 filings from S&P 500 Industrials constituents reveal a sector bifurcated between steady organic growth and rising cost pressures. Parker-Hannifin (PH) dominates the filing set with 12 insider equity awards and a comprehensive 10-K showing 8.3% revenue growth to $21.5B, but a sharp 600 bps increase in its effective tax rate (to 20.0%) and a swing to a $330M loss in other expense/income, compressing net income growth to just 3.3%. Northrop Grumman (NOC) issued a unique stock-price-linked retention grant to its CEO, signaling board focus on shareholder alignment. Illinois Tool Works (ITW) saw a director exercise and sell a combined ~$14M in stock, a notable insider liquidation. Boeing (BA) announced a routine but material C-suite succession. The dominant theme is capital allocation toward long-term incentive compensation (SARs and MSUs) across PH and NOC, while ITW's insider selling and PH's tax/income headwinds warrant caution. The portfolio shows no uniform margin trend, but PH's data points to a potential earnings quality concern from one-time items.

19 high priority 19 total filings
· daily

US Material Events SEC 8-K Filings — August 21, 2026

The August 21, 2026, filing cycle reveals a market bifurcated between aggressive capital-raising and strategic restructuring. A significant cluster of companies, including Applied Optoelectronics ($600M ATM), OS Therapies ($75M ATM), and Enova International ($301M securitization), are actively tapping equity and debt markets, signaling a high demand for growth or working capital. This is counterbalanced by a wave of corporate failures and restructurings, such as the termination of the BSTR/Cantor Equity Partners merger, the failed Mangoceuticals/Nuclea Energy deal, and the strategic review at NEXGEL. Insider activity is notably absent, with no major insider buying or selling detected across the 50 filings, suggesting a cautious or neutral stance from management. The most actionable themes are the refinancing of high-cost debt (Gray Media saving ~300 bps on $675M) and the emergence of distressed financing situations (Edgemode, Nexalin) that signal severe financial strain. The overall tone is one of strategic repositioning, with companies either fortifying balance sheets or facing existential challenges.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 21, 2026

Today's insider trading digest reveals a clear divergence between aggressive insider buying at deeply discounted valuations and significant, often 10b5-1 plan-driven, selling by top executives at growth and technology companies. The most notable buying signals emanate from 51Talk Online Education Group (CEO bought $3.19M), Prothena Corp (10% owner bought $439K), and Alico (director bought $50K), suggesting strong conviction in turnaround or value stories. Conversely, a wave of selling hit Sea Ltd (4 executives sold, including COO for $1.08M), Freshpet (CEO sold $3.07M), and Twist Bioscience (exec sold $1.84M), though much of this is pre-planned. A cluster of insider purchases at Lument Finance Trust (CEO and director bought $25K combined) and High Income Securities Fund (director bought $134K) points to value-seeking in financials and closed-end funds. The overall picture is one of cautious optimism in select value plays, while growth names see continued executive profit-taking. No material period-over-period comparisons or forward-looking guidance changes were available in the filings to alter this narrative.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 21, 2026

A massive wave of 16 8-K filings on a single day (August 21, 2026) reveals an acute corporate distress event across the US public markets, primarily concentrated in the healthcare and technology sectors. A staggering 15 of the 16 filings are from companies receiving Nasdaq deficiency or delisting notices, with materiality ratings of 8/10 or 9/10 in nearly every case. The three primary distress triggers are: (1) failure to maintain the minimum $1.00 bid price (5 companies: VivoSim Labs, Citius, BioCardia, Pasithea, Estrella), (2) failure to meet the minimum $2.5 million stockholders' equity requirement (4 companies: Silexion, TruGolf, Dragonfly Energy, Adial), and (3) failure to timely file periodic reports (3 companies: Global Interactive, SolarMax, Synergy CHC). The most severe cases involve Silexion Therapeutics and Rain Enhancement Technologies, which have already received delisting notices with imminent hearing deadlines; their shareholders' equity of only $44,000 and failure to cure market value deficiencies, respectively, place them in the highest risk category. This concentration highlights systemic weakness in micro-cap and pre-revenue biotech/life sciences companies that have been unable to access follow-on capital in a challenging market environment. There is no benign explanation for this cluster; it is a fundamental capital structure crisis.

16 high priority 16 total filings
· daily

Global High-Priority Regulatory Events — August 21, 2026

This digest covers 50 filings from August 21, 2026, revealing a market bifurcated between aggressive corporate restructuring and a wave of micro-cap distress. The most critical theme is a deluge of Nasdaq non-compliance notices, with 14 companies receiving deficiency warnings for low bid prices, insufficient equity, or delinquent filings, signaling a potential wave of micro-cap delistings. Concurrently, there is significant M&A and restructuring activity, including a $180M SPAC merger for Everli Global, a major insolvency admission for Satiate Agri Ltd (₹6.27 Cr default), and the final deregistration of QVC Group post-bankruptcy. Insider activity was limited, but a notable promoter acquisition in Orissa Bengal Carrier and a related-party acquisition by KPI Green Energy highlight specific capital allocation moves. The overarching theme is one of cleansing: distressed micro-caps face existential threats while larger entities pursue strategic consolidation and new ventures, creating a high-risk, high-opportunity environment for event-driven investors.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 21, 2026

Today's filings reveal a market bifurcated between aggressive corporate restructuring and operational stress. The most significant themes are a wave of M&A activity facing execution hurdles (LivePerson, BSTR Holdings, Simulations Plus) and a sharp deterioration in credit quality at smaller financials (GBank Financial). On the positive side, several companies are executing strategic refinancings (Methanex, Jefferson Capital) and capital allocation shifts (News Corp buyback). Insider selling at Sea Ltd by multiple C-suite executives under 10b5-1 plans is a notable bearish signal for the tech sector. The data shows a clear pattern of revenue growth being offset by margin compression and rising interest costs across industrials and consumer-facing companies (Sysco, Dingdong). The upcoming week is catalyst-heavy with key shareholder votes on transformative M&A (LivePerson, Pasqal, Simulations Plus) that will determine the fate of several high-profile deals.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 21, 2026

The five filings from the S&P 500 Consumer Discretionary sector for August 21, 2026, center exclusively on Home Depot and Yum! Brands, revealing a period of executive restructuring and insider capital movements rather than broad operational or financial updates. Home Depot dominates the filing activity with a series of insider transactions and an 8-K detailing expanded roles for three senior executives, each receiving $500,000 in restricted stock awards. The most critical development is the CFO's sale of $2.09 million in stock following an option exercise, which, while potentially part of routine tax planning, introduces a bearish signal given his oversight of the company's strategic 'Pro Acceleration' office. Yum! Brands' appointment of a new director is a low-materiality governance event. No period-over-period financial comparisons or forward-looking guidance were provided in any filing, limiting the ability to derive revenue or margin trends. The overall portfolio-level pattern is one of management realignment and insider activity, with no cross-cutting sector themes emerging from the limited data set.

5 high priority 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 21, 2026

The two S&P 500 Healthcare filings today reveal a pattern of insider selling, albeit at low materiality levels, suggesting routine portfolio management rather than acute bearish sentiment. Gilead Sciences shows a director executing a 10b5-1 plan with a net sale of ~$167K after exercising options, indicating pre-planned diversification. Intuitive Surgical's EVP sold a minimal ~$30.5K worth of stock, also under a 10b5-1 plan, reflecting standard compliance selling. No period-over-period trends, forward guidance, capital allocation changes, or M&A activity were present in these filings, limiting the depth of cross-company synthesis. The sector theme is muted insider activity with no red flags, but the lack of bullish signals (e.g., insider buying, guidance raises) keeps the overall tone neutral. Investors should monitor upcoming earnings calls and any shifts in insider behavior for clearer directional cues.

2 high priority 2 total filings
· daily

US Earnings Financial Results SEC Filings — August 21, 2026

The 13 filings reveal a bifurcated market: established industrial and tech companies (OSI Systems, Sysco, Ubiquiti, Parker-Hannifin) show moderate revenue growth (3-27% YoY) but face margin compression and rising costs, while a cluster of micro-cap and SPAC entities (Game Your Game, Bubblr, GridAI, Freedom Metals, FG Merger II) are in severe financial distress with collapsing revenues, widening deficits, and cash depletion. The banking sector (Kearny Financial) shows strong earnings growth (+39% YoY) but rising non-performing assets signal credit risk. Key themes include: 1) margin pressure from restructuring and impairment charges (OSI, GridAI), 2) a wave of cash-burning pre-revenue companies with negative sentiment, and 3) capital allocation diverging between buybacks/dividends (Ubiquiti, OSI) and debt-fueled survival (La Rosa). Insider trading data was sparse, but forward-looking statements from OSI and Parker-Hannifin suggest cautious optimism on organic growth. The most actionable signals are Ubiquiti's margin expansion and Kearny's earnings beat, while the highest risks are concentrated in the micro-cap cohort where cash runs are measured in months.

13 high priority 13 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 21, 2026

This batch of 12 proxy filings reveals a concentrated theme of capital structure engineering and shareholder dilution, particularly among small-cap and micro-cap companies. Theravance Biopharma's merger vote, Classover Holdings' massive authorized share increase, and VivoSim Labs' reverse split and warrant repricing are the most material events, each carrying significant implications for existing equity holders. While Neogen Corp stands out with a clear operational turnaround story—core revenue growth, deleveraging, and a planned 50% R&D increase—most other filings lack detailed financial performance data, limiting period-over-period comparisons. Insider trading activity is notably absent across all filings, which is a neutral signal but removes a key conviction indicator. The overarching theme is one of corporate action (mergers, dilutive financings, equity plan amendments) rather than operational performance, creating a high-risk, high-potential-reward environment for active investors. The forward-looking catalyst calendar is packed with special and annual meetings in September and October 2026, providing clear near-term event-driven opportunities.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 21, 2026

The IPO pipeline is active with 8 filings on August 21, 2026, spanning biotech, gaming, energy, and semiconductor sectors. The dominant theme is capital-intensive, pre-revenue or early-stage companies seeking public funding, with 5 of 8 filings being S-1 registrations for IPOs or follow-on offerings. A critical pattern is the prevalence of 'going concern' risks and heavy reliance on dilutive financing, particularly in the biotech space (Aptevo, Tempest, Alzamend). The largest transaction is ON Semiconductor's acquisition of Synaptics, a $4B+ deal that has seen the acquirer's stock price decline 30% since announcement, creating valuation uncertainty. Insider trading data is sparse, but capital allocation trends show a clear preference for equity financing over debt, with several companies using deep-discount convertible instruments (Alzamend) or at-the-market facilities (Tempest). The pipeline is characterized by high risk, high dilution, and speculative valuations, with few mature, profitable companies seeking public listing.

8 high priority 8 total filings
· daily

US Executive Officer Management Changes SEC — August 21, 2026

This digest covers 30 filings, with 21 new and 9 context items, focused on US executive and director changes. The most critical development is a leadership vacuum at **New Fortress Energy** (CFO resigned with no interim named) and a sudden COO termination at **Nerdy** without explanation, signaling potential operational distress. Conversely, **BJ's Wholesale Club** delivered standout operational results (sales +15.9% YoY, EPS +19.3%) and raised guidance, contrasting with mixed signals from **James River Group** (underwriting loss despite profit growth). A notable pattern is the strategic positioning of CFO appointments: **Vertical Data** hired a CPA to lead an uplisting, while **Synaptics** lost its CFO to a competitor amid a pending merger, creating execution risk. The overall tone is cautious, with 7 filings showing negative or mixed sentiment, but pockets of strength exist in consumer staples and niche financial services. Insider activity is sparse, but the capital allocation trend (dividend at United Fire Group, equity grants at Home Depot and Northrop Grumman) suggests a focus on retention and shareholder returns.

30 high priority 30 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 21, 2026

The 30 filings reveal a dynamic period of board and executive leadership changes across US-listed companies, with a notable concentration of CFO transitions and strategic realignments. Key themes include a wave of CFO appointments and departures, often tied to M&A activity or strategic pivots (e.g., Synaptics, Qnity Electronics, Vertical Data), and several board departures unrelated to company disagreements. While most changes are routine, several carry material implications: NEXGEL's leadership transition and strategic review, New Fortress Energy's sudden CFO resignation without an interim named, and Nerdy's unexplained COO termination signal elevated execution risk. On the positive side, BJ's Wholesale Club reported strong Q2 results with 15.9% revenue growth and raised guidance, while James River Group showed improved net income despite underwriting challenges. The period-over-period data from the two earnings filings shows a mixed picture: BJ's demonstrated robust top-line growth and margin discipline, while James River's group combined ratio of 100.2% indicates overall underwriting pressure. Insider trading activity was absent from these filings, but capital allocation signals were present through United Fire Group's continued dividend and Northrop Grumman's performance-based CEO retention grant. The overall sentiment across filings is predominantly neutral, with pockets of positive (BJ's, Qnity, United Fire) and negative (New Fortress Energy, Nerdy) signals.

30 high priority 30 total filings
· daily

USA Corporate Actions — August 21, 2026

The sole filing analyzed for August 21, 2026, is from Gabelli Dividend & Income Trust, which filed an 8-K amending the terms of its Series M Cumulative Preferred Shares. The key changes include extending the mandatory redemption date by two years to December 26, 2028, and introducing new holder put dates in 2027 and 2028, alongside a mandatory put mechanism in December 2026 with an opt-out provision. The authorized share count for the series was also increased from 30 million to 50 million. This corporate action is neutral in sentiment and moderate in materiality, reflecting a strategic restructuring of preferred share terms rather than a fundamental shift in the company's financial health. No period-over-period comparisons, insider trading activity, or forward-looking guidance were provided in the filing, limiting the depth of trend analysis. The primary takeaway is that the trust is proactively managing its capital structure to provide flexibility and optionality for preferred shareholders, which may appeal to income-focused investors.

1 medium 1 total filings
· daily

USA Insider Trading Pulse — August 21, 2026

The August 21, 2026 insider trading pulse reveals a pronounced bearish tilt, with 18 sell transactions versus 7 buy transactions, though many sells are executed under Rule 10b5-1 plans, reducing their alarmist signal. The most significant insider activity clusters in the technology and growth sectors, where multiple C-suite executives at Sea Ltd, Freshpet, and Twist Bioscience are monetizing equity awards, often at substantial gains. A notable insider buying theme emerges in the financial services and small-cap value space, with directors and CEOs at Lument Finance Trust, Alico, and NB Bancorp adding to their positions, signaling confidence in undervalued assets. The data also shows a wave of equity grants and awards at Parker-Hannifin and Calumet, indicating a focus on long-term incentive alignment. Overall, the digest suggests a market where growth insiders are taking profits while value-oriented insiders are deploying capital, pointing to a potential rotation away from high-multiple growth stocks toward more defensive, asset-backed names.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 21, 2026

The August 21, 2026 M&A and takeover landscape is dominated by SPAC activity, with 5 of 8 filings involving blank-check companies, signaling a continued but cautious market for de-SPAC transactions. A notable trend is the prevalence of regulatory and compliance challenges, as two SPACs (K&F Growth Acquisition Corp. II and Breeze Acquisition Corp. II) received Nasdaq deficiency notices for listing rule violations, highlighting heightened scrutiny on SPAC governance and reporting. The only operational company with a material transaction, Elutia Inc., executed a strategic divestiture of its SimpliDerm business for up to $11 million, generating non-dilutive capital to fund its high-potential NXT-41x product, though it now faces increased product concentration risk. Liberty Broadband Corp's filing signals a significant upcoming merger through the creation of a merger subsidiary, while RocketFuel Blockchain completed an undisclosed acquisition, creating uncertainty. The Bleichroeder Acquisition Corp. II filing provides specific deal economics for its Pasqal business combination, including a $1.85 million closing fee, offering a rare glimpse into SPAC sponsor incentives. Overall, the digest reveals a market where SPACs are navigating operational and regulatory hurdles, while select operating companies are reshaping their portfolios through targeted M&A.

8 high priority 8 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 20, 2026

The six insider sales filings from S&P 500 Technology leaders dominate intelligence, revealing broad-based executive profit-taking at sector highs. Despite a stellar earnings quarter from Applied Materials (net income up 44.5% YoY, EPS up 46.6%), a sharp capital allocation shift from buybacks to reinvestment suggests management sees higher growth returns from capex (+34.8% YoY), creating a nuanced outlook. A notable cluster of C-suite and board sales across AMD ($3M+ in CEO sales), Micron ($14M single insider sale), CrowdStrike ($806K CEO sale), Cisco, and Apple within 48 hours signals a potential sector peak. The stark divergence between AMD's weak insider sentiment (no insider purchases, only pre-planned sales) and its operational momentum remains the key market puzzle, while Micron's massive insider liquidation at $934 stock price flags extreme valuation risk.

7 high priority 1 medium 8 total filings
· daily

New Federal Contractors — August 20, 2026

The five contracts analyzed total $1.84 billion in obligations, all from civilian agencies with no defense-related awards, signaling a strong civilian procurement environment. The dominant theme is health and IT services, led by Emergent Product Development Gaithersburg Inc.'s massive $1.41 billion HHS contract, which alone accounts for 77% of total value and is the highest-conviction bullish signal. Other notable awards include Guidehouse Inc.'s $124.5 million DOJ ICAM contract and Managed Care Advisors Inc.'s $106.9 million CDC provider network deal, both reflecting stable civilian demand. However, the lack of defense contracts and the presence of three neutral signals (Yulista Tactical Services LLC, Managed Care Advisors Inc., Cherokee Strategic Solutions LLC) highlight execution and budget risks, particularly for fixed-price contracts like Cherokee's $81.8 million FAA weather systems award. Key watch items include option exercises for Guidehouse and Cherokee, and potential follow-on contracts for Emergent.

5 total filings
· daily

Significant Contract Modifications ($10M+) — August 20, 2026

This digest covers $1.84B in civilian agency contract obligations from August 20, 2026, with zero defense-related awards, underscoring a sharp divergence from DOD spending patterns. The dominant theme is a massive, sole-source-like $1.41B award to Emergent Product Development Gaithersburg Inc. from HHS, which accounts for 77% of total value and is the highest-conviction signal, though its lack of competitive detail introduces opacity. A competitive $124.5M ICAM win for Guidehouse Inc. at DOJ provides the clearest bullish signal for federal IT services. Key risks include the expired performance period for Yulista Tactical Services LLC’s $115M NASA contract and the early-stage execution risk on Cherokee Strategic Solutions’ $81.8M fixed-price FAA weather systems contract. Investors should watch for HHS budget justification for the Emergent award and DOJ option exercises on Guidehouse's contract.

5 total filings